WITHTECH Co., LTD. (KOSDAQ:348350)
9,040.00
+90.00 (1.01%)
At close: Aug 6, 2026
WITHTECH Co., LTD. Revenue
WITHTECH Co., LTD. had revenue of 7.29B KRW in the quarter ending March 31, 2026, a decrease of -14.29%. This brings the company's revenue in the last twelve months to 56.59B, up 29.88% year-over-year. In the year 2025, WITHTECH Co., LTD. had annual revenue of 57.81B with 32.54% growth.
Revenue (ttm)
56.59B
Revenue Growth
+29.88%
P/S Ratio
1.53
Revenue / Employee
247.12M
Employees
229
Market Cap
86.50B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 57.81B | 14.19B | 32.54% |
| Dec 31, 2024 | 43.62B | -5.95B | -12.00% |
| Dec 31, 2023 | 49.56B | -23.04B | -31.74% |
| Dec 31, 2022 | 72.61B | 4.30B | 6.29% |
| Dec 31, 2021 | 68.31B | 12.69B | 22.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| XEXYMIX | 276.36B |
| JLS Co.,Ltd. | 102.72B |
| Com2uS Holdings | 92.02B |
| Nice D&B | 92.02B |
| KOREA PHARMA | 91.42B |
| D&C Media | 84.97B |
| Choong Ang Vaccine Laboratory | 39.19B |
| WISEnut | 36.55B |